IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection.
about
Genetic variability of the core protein in hepatitis C virus genotype 4 in Saudi Arabian patients and its implication on pegylated interferon and ribavirin therapy.Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells.The efficacy of a Hansenula-derived 20 kDa pegylated interferon alpha-2a in the treatment of genotype 4 chronic hepatitis C.Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin.Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues.IL-28B polymorphisms correlated with treatment response in HCV-4 mono-infected patients: a meta-analysis.Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis.Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues.Role of IL28B for chronic hepatitis C treatment toward personalized medicine.Prevalence of Hepatitis C among Egyptian Children with Sickle Cell Disease and the Role of IL28b Gene Polymorphisms in Spontaneous Viral Clearance.Genotype CC of rs12979860 is providing protection against infection rather than assisting in treatment response for HCV genotype 3a infection.Hepatitis C virus genotype 1: how genetic variability of the core protein affects the response to pegylated-interferon and ribavirin therapy.
P2860
Q33574642-0EF5F30C-35D3-48AC-87CB-3519B86F4E4DQ33660974-AC02737E-9E09-4FB5-869A-398BA52F8284Q34113840-13466652-B800-472B-A606-12FBA25470BCQ34270336-F1499D88-267A-4419-A404-2C5AFBB5DFB3Q34645417-196B3257-CAB6-4B4C-A321-F10276930730Q35124008-5E8714EA-FFA9-414A-9688-69C2E73DF275Q36140466-2E375E06-CD89-4AAB-AE31-0F3A9D30A0E5Q37564156-FEE7AD82-95FF-4A3C-9D64-ED38D0B3E4EEQ38170161-423D828C-50A1-4093-B63B-0F7EF62FB0BAQ40841999-4963A2B9-AF98-4DBC-BD17-F56C767DABA9Q42214593-01471628-07B6-4458-84FC-5D9B808CC297Q42259303-CF19C6C1-CE14-424A-A4F7-3AC86B56058E
P2860
IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
IL28B polymorphisms predict th ...... C virus genotype 4 infection.
@en
type
label
IL28B polymorphisms predict th ...... C virus genotype 4 infection.
@en
prefLabel
IL28B polymorphisms predict th ...... C virus genotype 4 infection.
@en
P2093
P2860
P1476
IL28B polymorphisms predict th ...... C virus genotype 4 infection.
@en
P2093
Abdallah Al-Mdani
Ahmed Al-Qahtani
Ahmed Helmy
Ali Albenmousa
Ayman A Abdo
Faisal M Sanai
Faleh Z Al Faleh
Hamad I Al-Ashgar
Khalid Alswat
Mashael Al-Anazi
P2860
P2888
P304
P356
10.1007/S12072-013-9421-8
P577
2013-02-08T00:00:00Z